Cardiomyopathies with Mixed and Inapparent Morphological Features in Cardiac Troponin I3 Mutation

Dae-Won Sohn1, Hyung-Kwan Kim1, Yong-Jin Kim1

  • 1Division of Cardiology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.

Insights

A novel cardiac troponin I3 mutation causes mixed hypertrophic cardiomyopathy and left ventricular non-compaction features in a single family. This genetic finding highlights the complex presentation of cardiomyopathies and potential for early, unexpected deaths.

Area of Science:

  • Cardiovascular Medicine
  • Genetics
  • Molecular Biology

Background:

  • Genetic mutations in sarcomere proteins are known to cause various cardiomyopathies.
  • Mixed clinical and morphological features of different cardiomyopathies within a single patient are less understood.
  • Previous studies have not fully appreciated the spectrum of presentations for single gene mutations.

Purpose of the Study:

  • To investigate a novel mutation in cardiac troponin I3 (Arg186Gly).
  • To describe the mixed phenotypic expression of hypertrophic cardiomyopathy and left ventricular non-compaction in a family with this mutation.
  • To highlight the potential for early mortality associated with this genetic variant.

Main Methods:

  • Genetic sequencing to identify novel mutations in sarcomere protein genes.
  • Echocardiography and cardiac magnetic resonance imaging to assess cardiac morphology.
  • Family history review to document clinical outcomes and mortality.

Main Results:

  • A novel Arg186Gly mutation in the cardiac troponin I3 gene was identified.
  • Two family members presented with overlapping features of hypertrophic cardiomyopathy and left ventricular non-compaction.
  • These mixed cardiomyopathy features were not clearly defined for each individual type.
  • Four family members experienced premature deaths before age 30.

Conclusions:

  • A novel cardiac troponin I3 mutation can lead to a mixed phenotype of hypertrophic cardiomyopathy and left ventricular non-compaction.
  • This genetic mutation is associated with significant morbidity and premature mortality within affected families.
  • Further research is needed to understand the mechanisms underlying the variable and mixed presentations of cardiomyopathies.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
578
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
704
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
389
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
675
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
498
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
658